Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal

By David Moadel, InvestorPlace Contributor
Voyager Therapeutics' lucrative arrangement with a fellow biotech business is putting VYGR stock traders in a buying mood today.

Why Is Ocugen (OCGN) Stock Up Today?

By Dana Blankenhorn, InvestorPlace Contributor
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.

Why Is CinCor (CINC) Stock Up 138% Today?

By William White, InvestorPlace Writer
CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion.

The 7 Most Undervalued Value Stocks to Buy Now   

By Alex Sirois, InvestorPlace Contributor
Add these undervalued value stocks to your buy list. They still remain cheap and will remain in favor this year.

3 Biotech Companies to Watch in 2023

By Muslim Farooque, InvestorPlace Contributor
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC

By Bret Kenwell, InvestorPlace Contributor
Gene-editing stocks have not been immune when it comes to job losses and workforce reductions. Here are a few of the latest.

CureVac (CVAC) Stock Rises 25% on Positive Data for Covid-19 and Flu Vaccines

By Josh Enomoto, InvestorPlace Contributor
CureVac announced positive results for its mRNA-based Covid-19 and flu vaccine, which may offer tremendous relevance for CVAC stock.

CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal

By Josh Enomoto, InvestorPlace Contributor
CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock.

Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?

By Chris MacDonald, InvestorPlace Contributor
Biogen is in focus today with the company's lecanemab drug set for an FDA decision on approval, leading to bullish bets on BIIB stock.

7 Cheap Stocks That Wall Street Analysts Still Love

By Will Ashworth, InvestorPlace Contributor
The number of cheap stocks Wall Street analysts love might have gone down over the past year, but there are still plenty of options. 

7 Cheap Blue-Chip Stocks to Buy Before They Rebound

By Joel Baglole, InvestorPlace Contributor
As stocks overall remain at depressed prices, now's the time to build long-term positions in these seven cheap blue-chip stocks.

Why Is Fate Therapeutics (FATE) Stock Down 62% Today?

By William White, InvestorPlace Writer
Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech.

The 7 Best Dividend Stocks for Passive Income in 2023

By Ian Bezek, InvestorPlace Contributor
2022 has been a rough year for many kinds of investments. However, these seven dividend stocks are humming along with steadily rising yields.

7 Seriously Undervalued Dividend Stocks to Buy for High Total Returns

By Faisal Humayun, InvestorPlace Contributor
These undervalued quality dividend stocks provide a robust yield and also look poised for a breakout on the upside in the future.

Stock Market Predictions 2023: The One Word Investors Should Fear

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
At the top of my stock market predictions list is a scary word for investors... unemployment. Here's why Wall Street should be afraid.

NovoCure (NVCR) Stock Soars 50% on Positive Clinical Trial Results

By David Moadel, InvestorPlace Contributor
NVCR stock traders are undeniably pleased to see NovoCure marking a milestone in the company's quest to treat a specific type of lung cancer.

Why Investors Are Diving Into Relativity Acquisition (RACY) Stock

By Dana Blankenhorn, InvestorPlace Contributor
Relativity Acquisition was formed to buy into the legal cannabis industry, whose leaders are cash-hungry with stocks trading at lows.

Why Is Geron (GERN) Stock Soaring 50% Today?

By Josh Enomoto, InvestorPlace Contributor
Late-stage clinical biopharma Geron delivered positive results for its blood cancer therapeutic, dramatically lifting GERN stock.
Load More Articles